Cell and Gene Therapy Analysis
🇺🇸 FDAExpert commentary and market intelligence for pharma strategy teams
Showing 1–5 of 5 articles
Earlier
High impact AnalysisJun 4, 2026
Best Biotech News Sources: How Legend Biotech Emerged as a Rare Market Winner
6 min
Dr. Sarah MitchellCritical impact AnalysisJun 3, 2026
ASGCT Annual Meeting 2026: Live Event Coverage and Key Insights
6 min
Dr. Sarah MitchellHigh impact AnalysisJun 2, 2026
FDA Issues Draft Guidance to Help Accelerate Cell and Gene Therapies for Patients
FDA · cell and gene therapies · 7 min
Dr. Sarah MitchellHigh impact AnalysisApr 30, 2026
CAR-T Therapy Clinical Trials: Insights from ASCO 2026 and FDA Approval Implications
FDA · Oncology · 11 min
Dr. Natalie HughesMedium impact AnalysisApr 20, 2026
Medicare Coverage CAR-T Therapies: Policy Changes & Patient Impact 2024
CMS · oncology · 8 min
Dr. Sarah MitchellExplore intelligence